EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicing

Jessica J Lu, Giuseppe Deganutti iD, Miaomiao Li, Laura J Humphrys, Yandi Li, Theodore J Nettleton iD, Hariprasad Venugopal, Villy Julita, George Christopoulos, Christopher A Reynolds iD, Patrick M Sexton iD, Denise Wootten und 2 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2521157122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jessica J Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia. Hauptthemen laut MEDLINE: Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I, Alternative Splicing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pituitary adenylate cyclase-activating polypeptide (PACAP) 1 receptor (PAC1R) is a class B1 G protein–coupled receptor activated by the endogenous peptide agonists PACAP and vasoactive intestinal peptide (VIP). Alternate splicing within the receptor extracellular domain (ECD) generates the PAC1R short variant (PAC1sR) that has selectively enhanced VIP function compared to the full-length, PAC1R null variant (PAC1nR). However, to date, a comprehensive pharmacological assessment of the downstream signaling outcomes of PAC1sR activation compared to PAC1nR has not been performed, and little information is available to mechanistically understand how ECD splicing may alter ligand engagement. Here, we demonstrated that VIP, but not PACAP, has globally enhanced activity across a broad range of functional endpoints at PAC1sR compared to PAC1nR. Cryo-EM structures of VIP-bound, stimulatory G protein (G s )-coupled PAC1sR and PAC1nR, supported by molecular dynamics (MD) simulations, demonstrate transient engagement of the null loop in PAC1nR, which is absent in PAC1sR, with residues in extracellular loop 2 (ECL2) and the N-terminal helix of the ECD. These interactions result in differential engagement of VIP with these domains and the top of TM2/ECL1 with PAC1sR and PAC1nR. Moreover, MD simulations predicted differential interactions of the G s protein with the two PAC1R variants when bound by VIP that correlate with a greater allosteric influence of the G s protein on VIP affinity at the PAC1sR, relative to PAC1nR. Our study provides insights into the structural basis and functional consequences of PAC1R ECD splicing, increasing understanding of PAC1R ligand selectivity and signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IAlternative SplicingVasoactive Intestinal PeptideHumansLigandsMolecular Dynamics SimulationPituitary Adenylate Cyclase-Activating PolypeptideHEK293 CellsAnimalsCryoelectron MicroscopySignal TransductionProtein Binding

Stichwörter der Autor:innen

cryo-EMligand selectivitypituitary adenylate cyclase-activating polypeptide 1 receptorsplice variants

Substanzen

Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IVasoactive Intestinal PeptideLigandsPituitary Adenylate Cyclase-Activating Polypeptide

Autor:innen und Institutionen

  • Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
  • ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
  • Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, United Kingdom.
  • Ramaciotti Centre for Cryo Electron Microscopy, Monash University, Clayton, VIC 3800, Australia.

ORCID-Profile: Giuseppe Deganutti, Theodore J Nettleton, Christopher A Reynolds, Patrick M Sexton, Sarah J Piper

Zitieren

APA

Lu, J. J., Deganutti, G., Li, M., Humphrys, L. J., Li, Y., Nettleton, T. J., Venugopal, H., Julita, V., Christopoulos, G., Reynolds, C. A., Sexton, P. M., Wootten, D., Zhao, P., & Piper, S. J. (2025). Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicing. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2521157122

Vancouver

Lu JJ, Deganutti G, Li M, Humphrys LJ, Li Y, Nettleton TJ, et al. Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicing. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2521157122

BibTeX
@article{Lu2025,
  author = {Lu, Jessica J and Deganutti, Giuseppe and Li, Miaomiao and Humphrys, Laura J and Li, Yandi and Nettleton, Theodore J and Venugopal, Hariprasad and Julita, Villy and Christopoulos, George and Reynolds, Christopher A and Sexton, Patrick M and Wootten, Denise and Zhao, Peishen and Piper, Sarah J},
  title = {Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicing},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2521157122}
}
Kostenlos starten →